FAIRMOUNT FUNDS MANAGEMENT LLC BioCryst Pharmaceuticals, Inc. Transaction History

FAIRMOUNT FUNDS MANAGEMENT LLC portfolio value:

$32.04M
portfolio value

FAIRMOUNT FUNDS MANAGEMENT LLC quarter portfolio value change:

+19.09%
quarter

BioCryst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -23.93% -800K shares -3.32M $12.6 2.54M
Q2 2022 share Increase 0.00% 3.34M shares 35.37M $10.58 3.34M